Friday, November 18, 2016

Startup Invio Wins $170,000 Grand Prize at Seattle Angel Conference X

The Seattle Angel Conference (SAC), an investor-led startup competition connecting entrepreneurs and new angel investors, has awarded Seattle startup Invio a $170,000 investment grand prize.
Seattle (WA) -  The Seattle Angel Conference (SAC), an investor-led startup competition connecting entrepreneurs and new angel investors, announced today that Invio is the winner of the conference’s $170,000 investment grand prize.  Invio, Inc. was one of six finalist companies competing during the November 17, 2016, Seattle Angel Conference X. Invio has developed automation software to improve data quality for clinical trials while simultaneously driving down clinical operations costs, a $21 billion cost to industry today. “Our mission is to make more medical innovations feasible,” said Cassie Wallender, Chief Product Officer and Co-Founder. “This is achieved by leveraging the efficiencies of computer vision and machine learning.”
The finalists completed an exhaustive diligence process lasting several months, and the conference gave them a final opportunity to compete for the grand prize before an audience of investors and tech leaders.
Invio secured the $170,000 investment grand prize as the result of a group due diligence process over a 12-week period.
Invio team from L to R: Cassie Wallender, Dema Poppa, Saqib Rokadia, Brian Caruso.
“Seattle has emerged as a national force for innovation and entrepreneurial excellence,” said John Sechrest, Seattle Angel Conference founder.  “Seattle Angel Conference’s mission is to drive even greater growth and success in the startup community through a program of creating new Angel Investors by doing a slow-motion Angel Investment.”
Since 2012, the conference has trained over 200 first time angel investors, attracted over 650 companies and invested over two million dollars in 21 of the participating companies.
The Seattle Angel Conference winner and finalists are:
Invio, Inc.:  Its mission is eliminating clinical trial inefficiencies to propel medical innovations.

Articentral:  Helping small businesses list their handmade products on Etsy and Amazon Handmade with one click; Multriply: Enabling the tourist travel industry to reserve and organize tours and events; Prolaera: Continuing professional education for the 21st century; Sprawly: Enables anyone to build interactive 360 choose-your-own-adventure style content with zero technical knowledge needed, and WeedTraQR: Marijuana traceability seed to sale from smartphone.